Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: Promising options for prevention and treatment of uterine fibroids?
review
OA: green
CC0
⤵ 7 in-corpus citations
Abstract
Uterine leiomyomas (fibroids, myomas) are the most common benign tumors of female reproductive tract. They are highly prevalent, with 70-80% of women burdened by the end of their reproductive years. Fibroids are a leading cause of pelvic pain, abnormal vaginal bleeding, pressure on the bladder, miscarriage, and infertility. They are the leading indication for hysterectomy, and costs exceed 6 billion dollars annually in the United States. Unfortunately, no long-term medical treatments are available. Dysregulation of inflammatory processes are thought to be involved in the initiation of leiomyoma and extracellular matrix deposition, cell proliferation, and angiogenesis are the key cellular events implicated in leiomyoma growth. In modern pharmaceutical industries, dietary phytochemicals are used as source of new potential drugs for many kinds of tumors. Dietary phytochemicals may exert therapeutic effects by interfering with key cellular events of the tumorigenesis process. At present, a negligible number of phytochemicals have been tested as therapeutic agents against fibroids. In this context, our aim was to introduce some of the potential dietary phytochemicals that have shown anti-inflammatory, antiproliferative, antifibrotic, and antiangiogenic activities in different biological systems. This review could be useful to stimulate the evaluation of these phytochemicals as possible therapies for uterine fibroids.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (100)
- A low concentration of genistein induces estrogen receptor-alpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells via openalex
- Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells via openalex
- Are uterine leiomyoma a consequence of a chronically inflammatory immune system? via openalex
- Diet and uterine myomas via openalex
- [Histological and biochemical studies of collagen in human uterine leiomyomas]. via openalex
- Inhibitory effect of curcumin on uterine leiomyoma cell proliferation via openalex
- Predictors of hysterectomy: An Australian study via openalex
- Stimulatory and inhibitory effects of genistein on human uterine leiomyoma cell proliferation are influenced by the concentration via openalex
- W1488173460 via openalex
- W1964342723 via openalex
- W193787379 via openalex
- W1964698686 via openalex
- W1964917035 via openalex
- W1966230346 via openalex
- W116555158 via openalex
- W1964084914 via openalex
- W1968104658 via openalex
- W1963810274 via openalex
- W135809474 via openalex
- W1968267349 via openalex
- W1968404863 via openalex
- W1969018878 via openalex
- W1969955892 via openalex
- W1969989426 via openalex
- W1971422523 via openalex
- W1972965249 via openalex
- W1973390591 via openalex
- W1974264070 via openalex
- W1977015790 via openalex
- W1977101823 via openalex
- W1967940610 via openalex
- W1980236411 via openalex
- W1967105259 via openalex
- W1946251822 via openalex
- W1979588189 via openalex
- W1982254231 via openalex
- W1982605706 via openalex
- W1984093965 via openalex
- W1984650752 via openalex
- W1987015092 via openalex
- W1987231873 via openalex
- W2031594566 via openalex
- W1987964684 via openalex
- W1989043903 via openalex
- W1989463526 via openalex
- W1990434243 via openalex
- W1991201692 via openalex
- W1992716708 via openalex
- W1993649166 via openalex
- W1994341587 via openalex
- W1978231660 via openalex
- W1995654099 via openalex
- W1995827857 via openalex
- W1997213260 via openalex
- W1998401995 via openalex
- W2001641852 via openalex
- W2002156365 via openalex
- W2002175587 via openalex
- W2002245500 via openalex
- W2002449811 via openalex
- W2005679540 via openalex
- W2005859751 via openalex
- W1967077010 via openalex
- W2012968222 via openalex
- W2011502135 via openalex
- W1977461710 via openalex
- W2013546250 via openalex
- W2013552453 via openalex
- W2013653552 via openalex
- W2014231566 via openalex
- W2014994159 via openalex
- W2016601293 via openalex
- W2018571031 via openalex
- W2020064845 via openalex
- W2020618233 via openalex
- W2021570098 via openalex
- W2021731647 via openalex
- W2022368191 via openalex
- W2025231663 via openalex
- W2027823401 via openalex
- W2028045356 via openalex
- W2028720415 via openalex
- W2030104903 via openalex
- W2030127581 via openalex
- W2009881284 via openalex
- W2033367275 via openalex
- W2035346924 via openalex
- W2036301587 via openalex
- W2036826999 via openalex
- W2037627213 via openalex
- W2037652627 via openalex
- W2038187853 via openalex
- W2040011148 via openalex
- W2043041807 via openalex
- W2043422798 via openalex
- W2043620261 via openalex
- W2044238754 via openalex
- W2044765890 via openalex
- W2048544668 via openalex
- W2007546842 via openalex
Cited by (7)
- Epigenetic Modulation of Inflammatory Pathways in Myometrial Stem Cells and Risk of Uterine Fibroids 2023
- Insulin resistance and other risk factors of cardiovascular disease amongst women with abnormal uterine bleeding 2022
- Extracellular matrix remodeling and inflammatory pathway in human endometrium: insights from uterine leiomyomas 2021
- Insulin resistance and other risk factors of cardiovascular disease in abnormal uterine bleeding 2021
- Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies† 2021
- Inhibitory and protective effect of obovatol against uterine fibroid (leiomyoma) cells. 2020
- Dietary phytochemicals for possible preventive and therapeutic option of uterine fibroids: Signaling pathways as target 2016
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK